Theralase Technologi (TLTFF) 0.3130 $TLTFF Theralase

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Theralase Technologi (TLTFF) 0.3130 $TLTFF

Theralase Discovers Anti-Cancer Drug Fluoresces in Tissue
ACCESSWIRE - Thu May 14, 6:03AM CDT
TORONTO, ON / ACCESSWIRE / May 14, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TLT:TSXV) (TLTFF: OTC Pink), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, has discovered that its lead anti-cancer drug, TLD-1433, emits a fluorescent signature when light activated in a Non-Muscle Invasive Bladder Cancer ("NMIBC" animal model.
TLT.VN: 0.365 (-0.055)

Theralase Manufactures High Purity Anti-Cancer Drug
Filing Services Canada XHTML - Tue May 12, 6:02AM CDT

TLT.VN: 0.365 (-0.055)

Theralase 2014 Annual Results: Maintaining Buy Recommendation
Anita Dushyanth - at Seeking Alpha - Tue May 05, 8:51AM CDT


Pain Management Devices - Global Strategic Business Report 2015 - Neurostimulation Devices: The Future of Pain Management?
M2 - Tue May 05, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bzbgcw/pain_management) has announced the addition of the "Pain Management Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Pain Management Devices in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 34 companies including many key and niche players such as: - Bio-Medical Research (BMR) Ltd. (Ireland) - Boston Scientific Corp. (US) - Codman & Shurtleff, Inc. (US) - DJO Global, Inc. (US) - Halyard Health (US) - Medtronic, Inc. (US) - Smiths Medical (UK) - St. Jude Medical, Inc. (US) - NeuroTherm? (US) - Stryker Corporation (US) - Theralase Technologies Inc. (Canada) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS/DRIVERS & ISSUES 3. LEADING PAIN MANAGEMENT DEVICE TYPES 4. PRODUCT OVERVIEW 5. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 34 (including Divisions/Subsidiaries - 35) - The United States (25) - Canada (1) - Europe (7) - - France (1) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (2) For more information visit http://www.researchandmarkets.com/research/bz...management
HYH: 42.35 (-0.75), BSX: 17.85 (-0.06), MDT: 76.42 (+0.16), STJ: 74.96 (+0.47), SYK: 95.51 (+0.25)

Theralase Increases Revenue 15% in 2014 Financials
ACCESSWIRE - Fri May 01, 9:14AM CDT
TORONTO, ON / ACCESSWIRE / May 1, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TLT: TSXV) (TLTFF: OTC Pink(R)) released its 2014 financial results today, demonstrating an increase of 15% year over year in revenue.
TLT.VN: 0.365 (-0.055)

Theralase Manufactures First Pre-Commercial Batch of Lead Anti-Cancer Drug
ACCESSWIRE - Thu Apr 09, 6:05AM CDT
TORONTO, ON / ACCESSWIRE / April 9, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TSX VENTURE:TLT) (PINKSHEETS:TLTFF(R)) announced today that it has successfully manufactured the first pre-commercial batch of its lead anti-cancer Photo Dynamic Compound ("PDC" , TLD-1433, one of a new generation of unique light-activated anti-cancer compounds, specifically developed for the treatment of cancer.
TLT.VN: 0.365 (-0.055)

Theralase Holds pre-CTA Meeting with Health Canada
ACCESSWIRE - Thu Apr 02, 6:15PM CDT
TORONTO, ON / ACCESSWIRE / April 2, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TSX-VENTURE:TLT) (PINKSHEETS:TLTFF) announced today that it recently held a pre "Clinical Trial Application" ("CTA" consultation meeting with Health Canada ("HC" with the objective of presenting its Photo Dynamic Therapy ("PDT" technology in the treatment of cancer and seeking clinical trial design guidance.
TLT: 121.59 (+2.39), TLT.VN: 0.365 (-0.055)

Theralase Partners with CiToxLAB for Toxicology
ACCESSWIRE - Mon Mar 23, 6:05AM CDT
TORONTO, ON / ACCESSWIRE / March 23, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today that it has partnered with CiToxLAB Safety and Health Research Laboratories ("CiToxLAB" to provide toxicology and safety pharmacology for the lead anti-cancer Photo Dynamic Compound ("PDC" , TLD-1433.
TLT.VN: 0.365 (-0.055)

Theralase Confirms Strategic Initiatives
ACCESSWIRE - Wed Mar 11, 6:21AM CDT
TORONTO,ON / ACCESSWIRE / March 11, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company" (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today confirmation of its strategic initiatives for 2015.
TLT.VN: 0.365 (-0.055)

Theralase's Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug
ACCESSWIRE - Fri Feb 13, 6:04AM CST
Toronto, ON / ACCESSWIRE / February 13, 2015 / Theralase Technologies Inc. ("Theralase" (TLT:TSXV) (TLTFF: OTC Pink(R)), a developer of advanced Photo Dynamic Therapy ("PDT" , for serious and life-threatening diseases, announced today that research on its Anti-Cancer Technology ("ACT" platform involving its lead Photo Dynamic Compound ("PDC" TLD-1433 has shown that it has significantly less skin toxicity than the Food and Drug Administration ("FDA" approved PDC Photofrin(R).
TLT.VN: 0.365 (-0.055)

Theralase Ranked in 2015 Toronto Stock Exchange Venture 50(tm)
ACCESSWIRE - Wed Feb 11, 8:19AM CST
Toronto, ON / ACCESSWIRE / February 11, 2015 / Theralase Technologies Inc. ("Theralase" (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today that it has been ranked in the Toronto Stock Exchange Venture ("TSXV" 50(R).
TLT.VN: 0.365 (-0.055)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 79

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
League's AI Launch: A New Era in Healthcare

Updated Category News Views 76

AI: Healthcare's Bold New Move Ah, here we go. Another tech jump in healthcare. This time it's the folks over at League, stirring the pot with some new AI gimmicks. They've slapped together what they call an 'AI Front Door' and an 'AI Care Companion'—part of their Forge by League platform. Now, if there's one thing we know, it's that the healthcare sector loves a good...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 24

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 73

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
S&P Global's Bold $2 Billion Debt Offering Details

Updated Category News Views 80

Drilling Down into S&P Global's Debt Move S&P Global's throwing its hat in the ring with a colossal $2 billion debt offering. Now, they aren't just setting it on the table — they're notably carving it up into three chunks. You’ve got $750 million at 5.600% that comes due in 2031, $600 million at 5.800% for 2034, and $650 million at a 6.000% rate maturing in 2036....

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 88

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 158

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 110

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 120

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading

Top 5 Most Recently Viewed Articles

BriteCap Financial Achieves Major Funding Milestone

Updated Category News Views 124

BriteCap Financial Achieves Major Funding Milestone BriteCap Financial, a leading small business funding platform, has proudly announced that it has surpassed $1 billion in total originations since its inception. This impressive milestone was achieved in late 2025, highlighting a year of remarkable growth and success for the company. Record Growth in 2025 The achievement...

Continue Reading
Aker Horizons ASA's Upcoming Virtual Annual Meeting Details

Updated Category News Views 261

Aker Horizons ASA Announces Details of Virtual Annual Meeting Aker Horizons ASA, a key player in green energy solutions, has scheduled its annual general meeting to take place online. This digital event will allow shareholders to engage and participate from any location, enhancing accessibility for all stakeholders. Details on the Virtual Meeting The annual general...

Continue Reading
Integrated Analytical Solutions Opens New Cannabis Lab Facility

Updated Category News Views 165

Integrated Analytical Solutions Launches a New Cannabis Testing Facility Integrated Analytical Solutions (IAS), renowned for its analytical testing services, is making strides in the cannabis industry with the grand opening of its state-of-the-art cannabis testing laboratory. This facility is a significant addition to services aimed at promoting safety, quality, and...

Continue Reading
Trip.com Group Files 2024 Annual Report with SEC Insights

Updated Category News Views 1309

Trip.com Group Limited Files Annual Report on Form 20-F Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) has announced the submission of its annual report on Form 20-F. This report includes the company's audited financial statements covering the three years leading up to December 31, 2024, presented to the Securities and Exchange Commission. The filing was made recently...

Continue Reading
Revolutionizing Pediatric Healthcare: Office Practicum's Portal

Updated Category News Views 254

Transforming Pediatric Healthcare with an Innovative Portal Office Practicum is leading the charge in pediatric care by introducing a state-of-the-art Patient Portal, created in partnership with BridgeInteract. This comprehensive tool has been tailored specifically for pediatric practices, presenting a modern and user-friendly platform that serves both families and...

Continue Reading